Ameritox Licenses Ridge Diagnostics' Depression Biomarker Test | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – San Diego-based Ridge Diagnostics today said that it has licensed exclusive rights to Ameritox to its MDDScore, a multiplex biomarker test for major depressive disorder.

Ameritox, a Baltimore-based specialized lab testing firm, also will make an undisclosed equity investment in Ridge and has committed to a next-stage clinical development program.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Familial DNA searches in criminal cases are winning over some critics, the Los Angeles Times reports.

In Nucleic Acids Research this week: ProTraits includes genetic, phenotypic data on bacteria, archaea; Candida albicans assembly 22; and more.

The Wall Street Journal reports that researchers are looking beyond Cas9 for CRISPR editing.

In PNAS this week: miR-515 levels higher in women with preeclampsia, horizontal gene transfer in parasitic plants, and more.